Neulogy Ventures

Managing Partner Christian Mandl leads the investment team alongside Partner Jaroslav Luptak and Principal David Szedely. The firm's investment committee benefits from the operators' own entrepreneurial backgrounds — a principle the team emphasizes as central to their founder-aligned approach. Mandl and Luptak have been with the firm since its 2014 launch.

Neulogy's partnership with over 40 local entrepreneurs and ecosystem participants serves as a primary sourcing engine, reinforced by institutional relationships with the European Investment Fund and Slovak Investment Holding. The firm's stated strategy targets companies established or operating in Slovakia, with portfolio companies now spanning 10 countries — suggesting a network effect that pulls deals across Central and Eastern Europe beyond the initial geographic mandate.

Neulogy is regulated by Luxembourg's CSSF as a venture capital fund, which imposes reporting and governance standards beyond what a purely local Slovak fund would face. This structure allows the firm to include institutional LPs like the EIF, SIH, and Tatra banka, while maintaining flexibility to write first checks of €200K to €3M. The regulatory posture is rare for a fund deploying almost entirely into early-stage CEE startups.

Neulogy invests from early-stage through expansion and late-stage venture rounds. Initial check sizes range from €200K to €3 million (per the firm, 2024), positioning the fund for seed and Series A leads or co-leads in the Slovak and adjacent CEE markets. The firm does not operate a separate growth-stage vehicle.

The firm does not list explicit sector exclusions, but its portfolio aggregates under B2B SaaS, cleantech, cybersecurity, infrastructure, marketplace, medtech, and VR/XR — with a stated focus on deeptech investments that leverage CEE engineering capacity. Consumer internet, gaming, and advertising technology are absent from the current portfolio, suggesting a de facto exclusion of non-deeptech, non-technical verticals.

Neulogy does not operate a separate philanthropic foundation, but its stated investment principles include a triple-bottom-line framework — reconciling Planet, People, and Profit — and it follows the Invest Europe ESG Reporting Guidelines with portfolio companies. The fund frames this as an operational commitment rather than a parallel impact vehicle.

The firm states it assists portfolio companies with fundraising beyond its own capital, and takes a long-term view with no pressure for fast exits — suggesting a cooperative approach to syndication rather than a proprietary follow-on strategy. The acquisition of Trustmatic by Certn (per the firm, 2023) indicates Neulogy-backed companies can attract and integrate into North American acquirers, which may serve as a co-investment signal for external VCs evaluating CEE deals.